Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,102Revenue (TTM) $M190Net Margin (%)-67.0Altman Z-Score-0.1
Enterprise Value $M1,098EPS (TTM) $-3.5Operating Margin %-61.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score5.0Pre-tax Margin (%)-67.2Higher ROA y-yY
Price/Book44.010-y EBITDA Growth Rate %--Quick Ratio2.9Cash flow > EarningsN
Price/Sales5.65-y EBITDA Growth Rate %--Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-60.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M51.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CHRS is held by these investors:



CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Herman Alan C.Chief Scientific Officer 2017-03-01Sell11,333$24.19-10.91view
Herman Alan C.Chief Scientific Officer 2017-02-01Sell11,333$27.37-21.26view
Viret Jean-FredericCFO 2017-01-25Sell3,900$27-20.19view
Herman Alan C.Chief Scientific Officer 2017-01-03Sell11,333$27.95-22.9view
Viret Jean-FredericCFO 2016-12-16Sell3,900$28.3-23.85view
Wahlstrom MatsDirector 2016-12-08Sell53,583$27.52-21.69view
Herman Alan C.Chief Scientific Officer 2016-12-01Sell11,333$27.4-21.35view
Viret Jean-FredericCFO 2016-11-18Sell3,900$28.19-23.55view
Herman Alan C.Chief Scientific Officer 2016-11-01Sell11,333$27.53-21.72view
Viret Jean-FredericCFO 2016-10-21Sell3,900$30.62-29.62view

Press Releases about CHRS :

Quarterly/Annual Reports about CHRS:

News about CHRS:

Articles On GuruFocus.com
Coherus Biosciences' Humira Petition Denied Nov 08 2016 
A Look at Pharma Company Dermira's Performance Mar 27 2015 

More From Other Websites
Coherus BioSciences, Inc. :CHRS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
COHERUS BIOSCIENCES, INC. Financials Mar 17 2017
Coherus BioSciences, Inc. :CHRS-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017 Mar 16 2017
COHERUS BIOSCIENCES, INC. Files SEC form 10-K, Annual Report Mar 14 2017
Edited Transcript of CHRS earnings conference call or presentation 13-Mar-17 8:30pm GMT Mar 13 2017
Coherus BioSciences Inc Earnings Call scheduled for 4:30 pm ET today Mar 13 2017
Coherus BioSciences reports 4Q loss Mar 13 2017
Coherus BioSciences reports 4Q loss Mar 13 2017
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 13 2017
Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial... Mar 13 2017
Q4 2016 Coherus BioSciences Inc Earnings Release - After Market Close Mar 13 2017
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 06 2017
Coherus Addresses Trade Secret Action Filed by Amgen Mar 06 2017
COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 03 2017
Statement by Coherus CEO Regarding Biosimilars User Fees Mar 02 2017
Coherus Announces CHS-1420 Pharmacokinetic Clinical Bioequivalence Study Meets Primary Endpoint Mar 02 2017
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March Mar 01 2017
Coherus BioSciences to Report Fourth Quarter and Full Year 2016 Financial Results on March 13th Feb 21 2017
Coherus BioSciences Announces New Employment Inducement Grants Feb 17 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)